Our data show that circulating neutrophils, monocytes and Tregs are a source of increased FV in patients with severe COVID-19, both within the bloodstream and within lung parenchyma, and that FV but not thrombin activated FVa decreases T-cell proliferation in vitro. Here, F5 is linked to COVID-19.